Delivery Order SPE2DB20D1004-SPE2DB25FNJTH
- Not listed
- The Defense Logistics Agency awarded a $1,926.55 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Tacrolimus 1 mg capsules (100-count units). This firm fixed price contract, which is not set-aside, represents a single delivery order against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and running through December 2026. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Tacrolimus 1 mg capsules (immediate release) in quantities of 100 units, with a ceiling value of $2,021.12. This is a firm fixed price delivery order with no set-aside designation, utilizing competitive procurement procedures. The contract will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 13,...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Tacrolimus 5 mg capsules (immediate release) in quantities of 100 units. The contract, valued at $67,741.38, was competitively awarded on July 18, 2025, with an ultimate completion date of July 21, 2025. This delivery order employs firm fixed pricing and carries no set-aside designation. AmerisourceBergen will perform the work at its corporate headquarters in...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Tacrolimus 5 mg capsules (immediate-release). The contract is valued at $4,320.54 and has a period of performance through September 26, 2024. This order is placed under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, which has a ceiling value of up to $999,999,999 and is used to...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Tacrolimus 1 mg capsules, an immunosuppressant medication. The delivery order has a ceiling value of $2,488.03 and a completion date of July 11, 2025. The contract is a firm fixed-price type and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant...
- This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $14,773.24 firm-fixed-price contract is for the delivery of Tacrolimus 5 mg capsules, an immunosuppressant medication. The contract has a period of performance through June 11, 2025 and is not set aside for any particular business type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,767.09, is for the delivery of TACROLIMUS 1 MG CAPSULE (IR) 100S, a medication used for various medical treatments. The contract is a Delivery Order awarded under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 100 units of 5 mg Tacrolimus capsules. The $1,903.26 contract has a period of performance through March 22, 2024 and does not have a set-aside designation. AmerisourceBergen Drug Corp is the prime contractor and is the sole awardee of a $999,999,999.00 indefinite delivery contract from DLA to deliver pharmaceuticals...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a pharmaceutical distribution company, for the supply of Tacrolimus 1 mg capsules. The award is a firm-fixed price contract with a ceiling value of $4,305.10 and an ultimate completion date of November 16, 2021. AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc., is a major supplier of pharmaceutical products and medical supplies to various federal agencies,...
- The Defense Logistics Agency awarded a delivery order valued at approximately $583 to Amerisourcebergen Drug Corporation for tacrolimus 1 mg capsules. Under the terms of the award, Amerisourcebergen will provide 100 capsules of the immunosuppressant drug to support the Defense Logistics Agency's medical supply needs. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a period of one day from September 11-12, 2023. The award was made on a firm-fixed-price...
- SPE2DB20D1004Indefinite Delivery Contract
- SPE2DB20D1004-SPE2DB25FNJTHDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Tacrolimus 1 mg capsules (100-count units) with a contract ceiling value of $1,206.33. This firm fixed-price delivery order, with an ultimate completion date of July 31, 2025, represents a non-set-aside competitive award executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Tacrolimus is an immunosuppressant medication commonly used in transplant recipients and for treating certain autoimmune conditions, making it a critical pharmaceutical commodity within the federal military healthcare supply chain. As a prime vendor under the DLA pharmaceutical support vehicle, AmerisourceBergen Drug Corp supplies a comprehensive range of medications and medical products to support Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems worldwide. This delivery order exemplifies the company's role in fulfilling specific pharmaceutical requirements through the flexible framework of its broader IDC with the Defense Logistics Agency.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 7/30/25 |